Show simple item record

dc.contributor.authorCorkery, John
dc.contributor.authorGuirguis, Amira
dc.contributor.authorPapanti, Duccio
dc.contributor.authorOrsolini, Laura
dc.contributor.authorSchifano, Fabrizio
dc.contributor.editorZawilska, Jolanta
dc.date.accessioned2019-06-21T00:08:45Z
dc.date.available2019-06-21T00:08:45Z
dc.date.issued2018
dc.identifier.citationCorkery , J , Guirguis , A , Papanti , D , Orsolini , L & Schifano , F 2018 , Synthetic cathinones – prevalence and motivations for use . in J Zawilska (ed.) , Synthetic Cathinones : Novel Addiction and Stimulatory Psychoactive Substances . vol. 12 , Current Topics in Neurotoxicity , Springer International Publishing AG , Cham, Switzerland , pp. 153-189 . https://doi.org/10.1007/978-3-319-78707-7_9
dc.identifier.isbn9783319787060
dc.identifier.isbn9783319787077
dc.identifier.otherPURE: 16904066
dc.identifier.otherPURE UUID: 1e76556e-128f-40ef-a2ad-41d8dd6f3f8c
dc.identifier.urihttp://hdl.handle.net/2299/21387
dc.description.abstractThis chapter considers the prevalence of and motivations for use of synthetic cathinones. As part of the scene-setting, the availability, legal status, numbers of cathinones, number and quantities confiscated are reviewed. This leads to the first substantive section of the chapter—an epidemiological investigation of the nature and extent of what is known about the use of these molecules. The second major section is more qualitative in its approach to understanding motivations for the use of any drug, Novel Psychoactive Substances (NPS), and then synthetic cathinones. An examination is conducted of how cathinones may be compared to other stimulants and why particular cathinones may be preferred to others. The converse situation is then examined, what might be the motivations and reasons for ceasing to take cathinones and why this may not be a rational decision. A brief examination of the consequences of ceasing versus continued use is presented. As it is very likely that further synthetic cathinones will continue to emerge, it is important to gain a much fuller insight into what motivates or causes individuals to use or cease using these molecules, so that communities and societies can respond in appropriate ways to the varying challenges that face them and their citizens.en
dc.format.extent47
dc.language.isoeng
dc.publisherSpringer International Publishing AG
dc.relation.ispartofSynthetic Cathinones
dc.relation.ispartofseriesCurrent Topics in Neurotoxicity
dc.rightsOpen
dc.subjectSynthetic cathinones
dc.subjectEpidemiology
dc.subjectPrevalence
dc.subjectReasons
dc.subjectMotivations
dc.titleSynthetic cathinones – prevalence and motivations for useen
dc.contributor.institutionDepartment of Clinical and Pharmaceutical Sciences
dc.contributor.institutionCentre for Clinical Practice, Safe Medicines and Drug Misuse Research
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.contributor.institutionSchool of Life and Medical Sciences
dc.description.statusPeer reviewed
dc.relation.schoolSchool of Life and Medical Sciences
dc.description.versiontypeFinal Accepted Version
dcterms.dateAccepted2018
rioxxterms.versionAM
rioxxterms.versionofrecordhttps://doi.org/10.1007/978-3-319-78707-7_9
rioxxterms.licenseref.uriOther
rioxxterms.typeOther
herts.preservation.rarelyaccessedtrue
herts.rights.accesstypeOpen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record